Literature DB >> 9653988

The safety and efficacy of Australian tick-borne disease vaccine strains in cattle in Paraguay.

C M Brizuela1, C A Ortellado, E Sanabria, O Torres, D Ortigosa.   

Abstract

Glycerol preserved, frozen tick-borne disease vaccine strains developed in Australia were imported into Paraguay to test their safety in pregnant Holando heifers and their efficacy against challenge from inoculated local field strains of Babesia bigemina, B. bovis and Anaplasma marginale in Hereford X Criolla heifers. The two Babesia strains proved to be safe and the B. bovis K strain was very effective in providing immunity to a local field strain of B. bovis. The B. bigemina efficacy trial was inconclusive, possibly due to the avirulent nature of the local field strain used in challenge. The A. centrale strain did not prove to be as safe as would be desirable in safety trials, neither did it provide as good protection as the Babesia strains in the efficacy trial. It was concluded that the Babesia strains provided good protection against field challenge in Paraguay and were safe to use in highly susceptible cattle, however an alternative to A. centrale should be sought to provide protection against local strains of A. marginale.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9653988     DOI: 10.1016/s0304-4017(97)00047-2

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  4 in total

Review 1.  Antigens and alternatives for control of Anaplasma marginale infection in cattle.

Authors:  Katherine M Kocan; José de la Fuente; Alberto A Guglielmone; Roy D Meléndez
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

2.  Protective immunity induced by immunization with a live, cultured Anaplasma marginale strain.

Authors:  G Kenitra Hammac; Pei-Shin Ku; Maria F Galletti; Susan M Noh; Glen A Scoles; Guy H Palmer; Kelly A Brayton
Journal:  Vaccine       Date:  2013-05-09       Impact factor: 3.641

3.  Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale.

Authors:  Michael J Dark; Basima Al-Khedery; Anthony F Barbet
Journal:  Vaccine       Date:  2011-05-17       Impact factor: 3.641

Review 4.  Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics Approach.

Authors:  Rosa Estela Quiroz-Castañeda; Itzel Amaro-Estrada; Sergio Darío Rodríguez-Camarillo
Journal:  Biomed Res Int       Date:  2016-08-17       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.